Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Emergencies × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Endocrine 1

Conditions

Neuroendocrine Tumors 85 Thyroid Neoplasms 30 Thyroid Cancer, Papillary 27 Carcinoid Tumor 25 Neoplasms 24 Multiple Endocrine Neoplasia Type 1 20 Thyroid Carcinoma, Anaplastic 19 Neoplasm Metastasis 16 Carcinoma, Neuroendocrine 16 Carcinoma, Medullary 16 Pituitary Neoplasms 15 Pheochromocytoma 15 Adenocarcinoma, Follicular 15 Somatostatinoma 13 Paraganglioma 13 Carcinoma, Non-Small-Cell Lung 13 Carcinoma, Islet Cell 12 Pancreatic Neoplasms 11 Adenoma, Islet Cell 11 Insulinoma 10 Glucagonoma 10 Colorectal Neoplasms 10 Adrenocortical Carcinoma 10 Gastro-enteropancreatic neuroendocrine tumor 9 Gastrinoma 9 Pituitary ACTH Hypersecretion 8 Melanoma 8 Carcinoma 8 Breast Neoplasms 8 Sarcoma 7

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01471639 2025-08-15

Sprix

The Cleveland Clinic

Phase NA Completed

37 enrolled 7 charts

Emergencies, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡